R, A., JB, G., HJL, H., JFE, M., JB, M., AK, M., . . . M, N. (2025). Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes. The New England journal of medicine, 393(6), 533. https://doi.org/10.1056/NEJMoa2410659
Chicago Style (17th ed.) CitationR, Agarwal, et al. "Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes." The New England Journal of Medicine 393, no. 6 (2025): 533. https://doi.org/10.1056/NEJMoa2410659.
MLA (9th ed.) CitationR, Agarwal, et al. "Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes." The New England Journal of Medicine, vol. 393, no. 6, 2025, p. 533, https://doi.org/10.1056/NEJMoa2410659.
Warning: These citations may not always be 100% accurate.